MHRP and collaborators recently launched a Phase 1 trial in Thailand that will evaluate two HIV vaccine candidates with and without the Army's novel ALFQ adjuvant to gain insight into late boosting strategies and the effects of fractional dosing.
The Walter Reed Program-Nigeria (WRP-N) has completed the pilot phase of a PEPFAR-funded initiative to conduct community-led monitoring of HIV services across 10 states in Nigeria.
